BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11179380)

  • 1. Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.
    Boyce JD; Adler B
    Infect Immun; 2001 Mar; 69(3):1943-6. PubMed ID: 11179380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
    Chung JY; Wilkie I; Boyce JD; Adler B
    Vaccine; 2005 Apr; 23(21):2751-5. PubMed ID: 15780722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).
    Boyce JD; Adler B
    Infect Immun; 2000 Jun; 68(6):3463-8. PubMed ID: 10816499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.
    Chung JY; Wilkie I; Boyce JD; Townsend KM; Frost AJ; Ghoddusi M; Adler B
    Infect Immun; 2001 Apr; 69(4):2487-92. PubMed ID: 11254611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity and vaccine development in Pasteurella multocida infections.
    Adler B; Chancellor R; Homchampa P; Hunt M; Ruffolo C; Strugnell R; Wapling D
    J Biotechnol; 1996 Jan; 44(1-3):139-44. PubMed ID: 8717397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane protein H for protective immunity against Pasteurella multocida.
    Lee J; Kim YB; Kwon M
    J Microbiol; 2007 Apr; 45(2):179-84. PubMed ID: 17483806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a protective antigen, PlpB of bovine Pasteurella multocida strain LZ-PM.
    Wei X; Wang Y; Luo R; Qian W; Sizhu S; Zhou H
    Dev Comp Immunol; 2017 Jun; 71():1-7. PubMed ID: 28119019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a 39kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies.
    Ali HA; Sawada T; Hatakeyama H; Ohtsuki N; Itoh O
    Vet Microbiol; 2004 May; 100(1-2):43-53. PubMed ID: 15135512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice.
    Dabo SM; Confer A; Montelongo M; York P; Wyckoff JH
    Vaccine; 2008 Aug; 26(34):4345-51. PubMed ID: 18598730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice.
    Okay S; Ozcengiz E; Ozcengiz G
    Acta Microbiol Immunol Hung; 2012 Dec; 59(4):485-98. PubMed ID: 23195557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).
    Wu JR; Shien JH; Shieh HK; Chen CF; Chang PC
    Vaccine; 2007 May; 25(21):4140-8. PubMed ID: 17449151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida.
    Homchampa P; Strugnell RA; Adler B
    Vaccine; 1997 Feb; 15(2):203-8. PubMed ID: 9066039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides.
    Tatum FM; Tabatabai LB; Briggs RE
    Avian Dis; 2009 Jun; 53(2):169-74. PubMed ID: 19630220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of purified lipopolysaccharide or protein-oligosaccharide conjugates of Pasteurella multocida type 6:B in mice.
    Muniandy N; Love DN; Mukkur TK
    Comp Immunol Microbiol Infect Dis; 1998 Oct; 21(4):257-79. PubMed ID: 9775357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
    Harper M; John M; Edmunds M; Wright A; Ford M; Turni C; Blackall PJ; Cox A; Adler B; Boyce JD
    Vaccine; 2016 Mar; 34(14):1696-703. PubMed ID: 26892738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous protective immunization elicited in mice by Pasteurella multocida fur ompH.
    Garrido ME; Bosch M; Bigas A; Badiola I; Barbé J; Llagostera M
    Int Microbiol; 2008 Mar; 11(1):17-24. PubMed ID: 18683628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida.
    Shivachandra SB; Kumar A; Yogisharadhya R; Viswas KN
    Vaccine; 2014 Jan; 32(2):290-6. PubMed ID: 24280281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immune response and efficacy in chickens of vaccines prepared from P. multocida capsular type A grown in iron-depleted conditions.
    Gunawardana GA; Frost AJ; Wilkie I
    Br Poult Sci; 2004 Apr; 45 Suppl 1():S18-9. PubMed ID: 15222344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.